These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

62 related items for PubMed ID: 1855095

  • 1. ABMT for children AML: Italian experience. GITMO-AIEOP Groups.
    Meloni G, Vignetti M, Andrizzi C, Dallorso S, Bonetti F, Zanesco L, Madon E, Andolina M, Carella AM, De Laurenzi A.
    Bone Marrow Transplant; 1991; 7 Suppl 3():80-3. PubMed ID: 1855095
    [Abstract] [Full Text] [Related]

  • 2. Autologous bone marrow transplantation in children with acute myeloblastic leukemia: report from the Italian National Pediatric Registry (AIEOP-BMT).
    Vignetti M, Rondelli R, Locatelli F, Lanino E, Miniero R, Rossetti F, Meloni G.
    Bone Marrow Transplant; 1996 Nov; 18 Suppl 2():59-62. PubMed ID: 8932801
    [Abstract] [Full Text] [Related]

  • 3. [Allogenic bone marrow transplantation versus autograft in acute lymphoblastic leukemia, in second remission in 113 children. Results of the Grupo Español de Transplante de Medula Niños (GETMON)].
    Badell I, Ortega JJ, Muñoz A, Bureo E, Madero L, Olivé T, Cubells J, Maldonado MS, Baro J, Díaz MA.
    Sangre (Barc); 1996 Apr; 41(2):101-8. PubMed ID: 9045349
    [Abstract] [Full Text] [Related]

  • 4. Autologous bone marrow transplantation in patients with AML in first complete remission. Results of two different conditioning regimens after the same induction and consolidation therapy.
    Meloni G, De Fabritiis P, Carella AM, Mangoni L, Porcellini A, Marmont A, Mandelli F.
    Bone Marrow Transplant; 1990 Jan; 5(1):29-32. PubMed ID: 2404528
    [Abstract] [Full Text] [Related]

  • 5. BAVC regimen and autograft for acute myelogenous leukemia in second complete remission.
    Meloni G, Vignetti M, Avvisati G, Capria S, Micozzi A, Giona F, Mandelli F.
    Bone Marrow Transplant; 1996 Oct; 18(4):693-8. PubMed ID: 8899182
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. High-dose melphalan with autologous hematopoietic stem cell transplantation for acute myeloid leukemia: results of a retrospective analysis of the Italian Pediatric Group for Bone Marrow Transplantation.
    Cesaro S, Meloni G, Messina C, Pillon M, Proglia A, Lanino E, Caniggia M, Bagnulo S, Pession A, Locatelli F, Italian Pediatric Group for Bone Marrow Transplantation.
    Bone Marrow Transplant; 2001 Jul; 28(2):131-6. PubMed ID: 11509930
    [Abstract] [Full Text] [Related]

  • 9. Monoclonal antibody purging and autologous bone marrow transplantation in acute myelogenous leukemia in complete remission.
    De Fabritiis P, Ferrero D, Sandrelli A, Tarella C, Meloni G, Pulsoni A, Pregno P, Badoni R, De Felice L, Gallo E.
    Bone Marrow Transplant; 1989 Nov; 4(6):669-74. PubMed ID: 2819285
    [Abstract] [Full Text] [Related]

  • 10. Autologous bone marrow transplantation for patients with acute myeloblastic leukemia in relapse after autologous blood stem cell transplantation.
    de la Rubia J, Sanz GF, Martín G, Sempere A, Picón I, Carral A, Larrea L, Martínez J, Soler MA, Bonanad S, López F, Jarque I, Sanz MA.
    Bone Marrow Transplant; 1996 Dec; 18(6):1167-73. PubMed ID: 8971390
    [Abstract] [Full Text] [Related]

  • 11. Autologous or allogeneic bone marrow transplantation for acute myeloblastic leukemia in second complete remission. Importance of duration of first complete remission in final outcome.
    Tomás F, Gómez-García de Soria V, López-Lorenzo JL, Arranz R, Figuera A, Cámara R, Alegre A, Fernández-Rañada JM.
    Bone Marrow Transplant; 1996 Jun; 17(6):979-84. PubMed ID: 8807103
    [Abstract] [Full Text] [Related]

  • 12. [Autologous bone marrow transplantation for acute leukemia].
    Kataoka T, Miyamura K.
    Rinsho Ketsueki; 1991 Apr; 32(4):381-5. PubMed ID: 2067082
    [Abstract] [Full Text] [Related]

  • 13. Autologous stem cell transplantation in acute myeloid leukemia. Factors influencing outcome. A 13 year single institution experience.
    Martins C, Lacerda JF, Lourenço F, Carmo JA, Lacerda JM.
    Acta Med Port; 2005 Apr; 18(5):329-37. PubMed ID: 16611537
    [Abstract] [Full Text] [Related]

  • 14. Autologous bone marrow transplantation for extramedullary relapse in childhood leukemia. The AIEOP Group and the FONOP. Italian Association of Pediatric Hemato/Oncology.
    Messina C, Rondelli R, Valsecchi MG, Rossetti F, Miniero R, Meloni G, Locatelli F, Aricò M, Testi AM, Dini G, Arrighini A, Manfredini L, Dallorso S, Porta F, Uderzo C, Santoro N, Werner B, De Rossi G, Loiacono G, Andolina M, Lippi A, Favre C, Amici A, Lo Curto M, Masera G.
    Bone Marrow Transplant; 1996 Nov; 18 Suppl 2():40-2. PubMed ID: 8932797
    [Abstract] [Full Text] [Related]

  • 15. Autologous bone marrow transplantation for acute myeloid leukemia in remission or first relapse using monoclonal antibody-purged marrow: results of phase II studies with long-term follow-up.
    Ball ED, Wilson J, Phelps V, Neudorf S.
    Bone Marrow Transplant; 2000 Apr; 25(8):823-9. PubMed ID: 10808202
    [Abstract] [Full Text] [Related]

  • 16. [Bone marrow autotransplantation in acute myeloblastic leukemia in its first complete remission. The clinical results in 41 patients].
    Tomás JF, Gómez-García de Soria V, Pinilla I, Lamana M, Figuera A, Arranz R, Cámara R, Fernández-Villalta MJ, Alegre A, Fernández-Rañada JM.
    Med Clin (Barc); 1997 Feb 15; 108(6):201-6. PubMed ID: 9102484
    [Abstract] [Full Text] [Related]

  • 17. Consequences of cryopreserving first remission autologous marrow for use after relapse in patients with acute myeloid leukemia.
    Schiffman K, Clift R, Appelbaum FR, Sanders J, Bensinger W, Petersen FB, Rowley S, Hill R, Martin P, Storb R.
    Bone Marrow Transplant; 1993 Mar 15; 11(3):227-32. PubMed ID: 8467288
    [Abstract] [Full Text] [Related]

  • 18. Allogeneic and autologous bone marrow transplantation after consolidation therapy in high-risk acute myeloid leukemia in children. Towards a risk-oriented therapy.
    Ortega JJ, Díaz de Heredia C, Olivé T, Bastida P, Llort A, Armadans L, Torrabadella M, Massuet L.
    Haematologica; 2003 Mar 15; 88(3):290-9. PubMed ID: 12651268
    [Abstract] [Full Text] [Related]

  • 19. High-dose busulfan and melphalan before bone marrow transplantation for acute nonlymphoblastic leukemia.
    Martino R, Badell I, Brunet S, Sureda A, Torras A, Cubells J, Domingo-Albós A.
    Bone Marrow Transplant; 1995 Aug 15; 16(2):209-12. PubMed ID: 7581138
    [Abstract] [Full Text] [Related]

  • 20. Treatment of childhood acute lymphoblastic leukemia after the first relapse: curative strategies.
    Uderzo C, Dini G, Locatelli F, Miniero R, Tamaro P.
    Haematologica; 2000 Nov 15; 85(11 Suppl):47-53. PubMed ID: 11268324
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.